ArticleACS applied materials & interfaces2019

Micellar Formulation of Talazoparib and Buparlisib for Enhanced DNA Damage in Breast Cancer Chemoradiotherapy.

Allison N DuRoss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.